MODERATOR
:
SPEAKER
(S):
Myriam Armant, PhD, Technical Director, Center for Human Cell Therapy Boston., Harvard Medical School
Christopher Breuer, MD, Co-Director, Tissue Engineering Program, and Director, Center for Regenerative Medicine and Cell Based Therapies, Columbus, OH, Nationwide Children's Hospital
Description
Much experience has been attained to optimize the manufacturing process of suspended cells to ensure safety and efficacy. In this session, the speakers will discuss two examples where cells are immobilized to a scaffold for in-vivo use.
-
Discuss the challenges of developing a limbal stem cell graft to treat blindness.
-
Review the process in translating vascular tissue engineering to the clinic.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.